Patrycja Gazinska
Patrycja Gazinska Ph.D. is principal investigator and Scientific Lead for the Biobank Research Group. Her group’s main research profile concerns translational research using molecular and computational pathology, with a focus on understanding how tumour microenvironment features (in HNSCC and BC) predict clinical and biological aspects of disease.
For many years, Patrycja managed histopathology research projects and services for multidisciplinary teams at Kings College in London (KCL). Later, she led a Digital & Experimental Research Pathology unit at the Institute of Cancer Research (ICR) specializing in digital pathology (including image analysis) and molecular pathology (histological biomarkers development and optimisation), with specific application to TNBC. More recently she worked for AstraZeneca (AZ) in Cambridge, applying computational pathology frameworks to oncology phase III clinical trials and analysis of ultra-low HER2.
Patricja’s current research program aims to understand HNSCC and its radio-resistance with application of artificial intelligence and spatial profiling. She also continue close research collaboration in BC with KCL, ICR and Royal Marsden Hospital, UK. This includes immune-oncology projects aiming to identify immunologic pathways in residual disease, to benefit high-risk patients and a novel framework of capturing immune features in lymph nodes predictive of TNBC outcome.